Dr Amy B. Cadwallader joins Ethics Talk to discuss how critical medicine supply chains are identified and secured.

Facial transplantation provides a viable option for those patients with severe facial defects who are more likely to adapt to their new facial appearance.

Be cautious about drawing conclusions from a narrow sample of literature about private equity based on studies in one sector.

Private equity investments in health care have grown to over $750 billion in the past decade and include every segment of the US health sector.

Poor-quality antimicrobial medicines continue to proliferate across supply chains, threatening patients’ health and safety, especially in low- and middle-income regions.

CEA has been increasingly used to inform public and private organizations’ reimbursement decisions, benefit designs, and price negotiations worldwide.

If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.

Tension between realistic goals and unrealistic views about how to achieve them is compounded when patients are eager to revise a prior surgeon’s gender-affirming procedure.

Body mass index cutoffs are routinely used to assess eligibility for gender-affirming surgeries, yet they are not empirically based.

Reliable supply of quality-assured medicines is hard to maintain in refugee camps in low- and middle-income countries with conflict zones.